FDA Inspection
AIRIS PHARMA PRIVATE LIMITEDAIRIS PHARMA PRIVATE LIMITED – FDA Inspection, Feb 3, 2024
Record Details
This FDA Inspection record concerns AIRIS PHARMA PRIVATE LIMITED, with an inspection on February 3, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 8d3d39f3-fb15-49b4-90bd-a2a0cfbaf3be
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1228622
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of AIRIS PHARMA PRIVATE LIMITED
1| Date | Classification | Office | Project area |
|---|---|---|---|
| January 31, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for AIRIS PHARMA PRIVATE LIMITED
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.